Glioblastoma multiforme is one of the most common brain tumors in humans. The average survival after the diagnosis is 12-15 months. The current standard therapy is surgical resection and radiotherapy. In this work, we explore the effects of modified BBR compounds, combined with phototherapy, on GBM cell lines.
Glioblastoma multiforme is one of the most common brain tumors in humans. The average survival after the diagnosis is 12-15 months. The current standard therapy is surgical resection and radiotherapy. In this work, we explore the effects of modified BBR compounds, combined with phototherapy, on GBM cell lines.
In vitro studies of the effects of BBR-derived compounds and photodynamic therapy on human glioblastoma cells.
BRESCIANI, GIORGIA
2021/2022
Abstract
Glioblastoma multiforme is one of the most common brain tumors in humans. The average survival after the diagnosis is 12-15 months. The current standard therapy is surgical resection and radiotherapy. In this work, we explore the effects of modified BBR compounds, combined with phototherapy, on GBM cell lines.È consentito all'utente scaricare e condividere i documenti disponibili a testo pieno in UNITESI UNIPV nel rispetto della licenza Creative Commons del tipo CC BY NC ND.
Per maggiori informazioni e per verifiche sull'eventuale disponibilità del file scrivere a: unitesi@unipv.it.
https://hdl.handle.net/20.500.14239/14913